OTCMKTS:CRGS CurAegis Technologies (CRGS) Stock Price, News & Analysis → AI finds its first serious application (From Wall Street Star) (Ad) Free CRGS Stock Alerts Add Compare Share Share Today's Range N/A50-Day Range N/A52-Week Range N/AVolume5,900 shsAverage Volume18,448 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get CurAegis Technologies alerts: Email Address Ad True Market Insiders4 Cryptos BETTER than BitcoinFormer Wall Street Insider and Professional Money Manager Reveals 4 Cryptos BETTER Than BitcoinClick For My #1 FREE Crypto for 2024 About CurAegis Technologies Stock (OTCMKTS:CRGS)CurAegis Technologies, Inc. does not have significant operations. Previously, it was engaged in the development and marketing of technologies in the areas of wellness, safety, and power. The company was formerly known as Torvec, Inc. and changed its name to CurAegis Technologies, Inc. in June 2016. CurAegis Technologies, Inc. was founded in 1996 and is based in Rochester, New York. On August 4, 2021, an involuntary petition for liquidation under Chapter 7 was filed against CurAegis Technologies, Inc. in the U.S. Bankruptcy Court for the Western District of New York. On August 31, 2021, the involuntary petition was approved by the Court.Read More Ad True Market Insiders4 Cryptos BETTER than BitcoinFormer Wall Street Insider and Professional Money Manager Reveals 4 Cryptos BETTER Than BitcoinClick For My #1 FREE Crypto for 2024 CRGS Stock News HeadlinesNo headlines for this company have been tracked by MarketBeat.com Receive CRGS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for CurAegis Technologies and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings5/13/2020Today4/29/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorBusiness Services Industry Motor vehicle parts & accessories Sub-IndustryN/A Current SymbolOTCMKTS:CRGS Previous SymbolOTCMKTS:TOVC CUSIPN/A CIK1063197 Webwww.curaegis.com Phone(585) 254-1100Fax585-254-1105Employees7Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A The 10 Best AI Stocks to Own in 2024Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.Get This Free Report Key ExecutivesMr. James R. Donnelly (Age 43)Pres, CEO, COO & Director Comp: $175kMr. Richard A. Kaplan (Age 76)Exec. Director Comp: $65kMr. Keith E. Gleasman (Age 75)Co-Founder & Independent Director Mr. Jason Burke (Age 48)Chief Financial Officer Mr. Richard B. SullivanCorp. CounselMr. Brandon HudsonHead of ProductMore ExecutivesKey Competitors6D Global TechnologiesOTCMKTS:SIXDAccess Worldwide CommunicationsOTCMKTS:AWWCAcuityAdsOTCMKTS:ACUIFAdaptive MediasOTCMKTS:ADTMAdstarOTCMKTS:ADSTView All Competitors CRGS Stock Analysis - Frequently Asked Questions How were CurAegis Technologies' earnings last quarter? CurAegis Technologies, Inc. (OTCMKTS:CRGS) released its quarterly earnings results on Wednesday, May, 13th. The company reported ($0.02) earnings per share (EPS) for the quarter. What other stocks do shareholders of CurAegis Technologies own? Based on aggregate information from My MarketBeat watchlists, some companies that other CurAegis Technologies investors own include Allena Pharmaceuticals (ALNA), Arbutus Biopharma (ABUS), Matinas BioPharma (MTNB), Acasti Pharma (ACST), Aldeyra Therapeutics (ALDX), Ampliphi Biosciences (APHB), BIOLASE (BIOL), Clearside Biomedical (CLSD) and How do I buy shares of CurAegis Technologies? Shares of CRGS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:CRGS) was last updated on 4/29/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe #1 Biotech Stock to Have on Your Radar in 2024… Huge AlertsAI finds its first serious applicationWall Street StarThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportHe Is Giving Away BitcoinCrypto Swap ProfitsBitcoin Rockets To Record High But Buy THIS InsteadParadigm Press4 coins to be the “Next Bitcoin”True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CurAegis Technologies, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.